Showing results (1621-1630 of 1,651) with videos related to

Sort By:
Pageof 166
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to CollaborationThomas A Olson, Matthew J Murray, Carlos Rodriguez-Galindo, et al.
American Journal of Ophthalmology|September 27, 2024
Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral RetinoblastomaMattan Arazi, Alona Baum, Sandro Casavilca-Zambrano, et al.
JAMA Oncology|October 1, 2019
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical TrialJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Journal of the National Cancer Institute|September 28, 2020
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S Albain, Robert J Gray, Della F Makower, et al.
The New England Journal of Medicine|June 4, 2019
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast CancerJoseph A Sparano, Robert J Gray, Peter M Ravdin, et al.
The Journal of Infectious Diseases|September 4, 2020
Exportation of Monkeypox Virus From the African ContinentMatthew R Mauldin, Andrea M McCollum, Yoshinori J Nakazawa, et al.
Plos One|May 17, 2018
Multi-site evaluation of the LN34 pan-lyssavirus real-time RT-PCR assay for post-mortem rabies diagnosticsCrystal M Gigante, Lisa Dettinger, James W Powell, et al.
The New England Journal of Medicine|June 5, 2018
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
The New England Journal of Medicine|September 29, 2015
Prospective Validation of a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Bioorganic & Medicinal Chemistry|October 3, 2006
Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonistsDaniel P Walker, Donn G Wishka, David W Piotrowski, et al.
Pageof 166